title: Response to letter regarding article, "Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study".
authors.forename: Morten
authors.initials: M
authors.lastname: Lamberts
authors.forename: Jonas Bjerring
authors.initials: JB
authors.lastname: Olesen
authors.forename: Martin Huth
authors.initials: MH
authors.lastname: Ruwald
authors.forename: Carolina Malta
authors.initials: CM
authors.lastname: Hansen
authors.forename: Deniz
authors.initials: D
authors.lastname: Karasoy
authors.forename: Søren Lund
authors.initials: SL
authors.lastname: Kristensen
authors.forename: Lars
authors.initials: L
authors.lastname: Køber
authors.forename: Christian
authors.initials: C
authors.lastname: Torp-Pedersen
authors.forename: Gunnar Hilmar
authors.initials: GH
authors.lastname: Gislason
authors.forename: Morten Lock
authors.initials: ML
authors.lastname: Hansen
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D001281:Atrial Fibrillation / Q000188:drug therapy*; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006470:Hemorrhage / Q000139:chemically induced* / Q000401:mortality*; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000628:therapy*
chemical_list: D005343:Fibrinolytic Agents